HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles

Pharmacogenomics

Volumn 14, Issue 5, 2013, Pages 531-540

  Singh, Amit K ^a   Abhimanyu, ^b   Yadav, Awadh B ^a   Sharma, Sandeep ^a   Garg, Rajiv ^c   Bose, Mridula ^b   Misra, Amit ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF DELHI   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

cytokines; haplotype; HLA; microspheres; nitric oxide; PCR; RFLP; SNPs; VDR

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; ISONIAZID; NITRIC OXIDE; RIFABUTIN; TUMOR NECROSIS FACTOR ALPHA; CALCITRIOL RECEPTOR; HLA DRB1 ANTIGEN; VDR PROTEIN, HUMAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; GENE FREQUENCY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HLA DRB1 GENE; HUMAN; HUMAN CELL; IMMUNE RESPONSE GENE; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS; VDR GENE; CELL SURVIVAL; DRUG EFFECT; GENETICS; HAPLOTYPE; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; IMMUNITY, INNATE; ISONIAZID; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RIFABUTIN; TUBERCULOSIS;

EID: 84875949315     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.12     Document Type: Article

References (32)

1. McShane H. Susceptibility to tuberculosis - the importance of the pathogen as well as the host. Clin. Exp. Immunol. 133(1), 20-21 (2003 (Pubitemid 36791937)
2. Singh SP, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J. Infect. Dis. 148(4), 676-681 (1983 (Pubitemid 13021671)
3. Bothamley GH, Beck JS, Schreuder GM et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J. Infect. Dis. 159(3), 549-555 (1989 (Pubitemid 19065904)
4. Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J. Infect. Dis. 173(3), 669-676 (1996 (Pubitemid 26064069)
5. Crowle AJ, Ross EJ, May MH. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 55(12), 2945-2950 (1987 (Pubitemid 18008262)
6. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006
7. Rook GA, Steele J, Fraher L et al. Vitamin D3, g interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57(1), 159-163 (1986 (Pubitemid 16232232)
8. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2), 143-156 (2004 (Pubitemid 39094759)
9. Bornman L, Campbell SJ, Fielding K et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in west Africa: a case-control and family study. J. Infect. Dis. 190(9), 1631-1641 (2004 (Pubitemid 39411013)
10. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis. 179(1), 187-191 (1999 (Pubitemid 29028354)
11. Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355(9204), 618-621 (2000 (Pubitemid 30099469)
12. Babb C, Van Der Merwe L, Beyers N et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87(4), 295-302 (2007 (Pubitemid 46951033)
13. Selvaraj P, Narayanan PR, Reetha AM. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J. Med. Res. 111, 172-179 (2000 (Pubitemid 30495297)
14. Misra A, Hickey AJ, Rossi C et al. Inhaled drug therapy for treatment of tuberculosis. Tuberculosis (Edinb.) 91(1), 71-81 (2011
15. Verma RK, Singh AK, Mohan M, Agrawal AK, Misra A. Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems Ther. Deliv. 2(6), 753-768 (2011
16. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3(1), 23-35 (2003 (Pubitemid 37328697)
17. Sharma R, Muttil P, Yadav AB et al. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J. Antimicrob. Chemother. 59(3), 499-506 (2007 (Pubitemid 47073457)
18. Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur. J. Pharm. Sci. 32(2), 140-150 (2007 (Pubitemid 47285721)
19. Indian Genome Variation Consortium (IGVC). Genetic landscape of the people of India: a canvas for diseaser gene exploration. J. Genet. 87, 3-20 (2008
20. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39(5), 225-235 (1992
21. Abhimanyu, Mangangcha IR, Jha P et al. Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis. Infect. Genet. Evol. 11(5), 1015-1022 (2011
22. Khor CC, Vannberg FO, Chapman SJ et al. CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362(22), 2092-2101 (2010
23. Semnani RT, Mahapatra L, Moore V, Sanprasert V, Nutman TB. Functional and phenotypic characteristics of alternative activation induced in human monocytes by interleukin-4 or the parasitic nematode Brugia malayi. Infect. Immun. 79(10), 3957-3965 (2011
24. Vogt G, Nathan C. In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J. Clin. Invest. 121(10), 3889-3901 (2011
25. Flesh IEA, Kaufmann SHE. Activation of tuberculostatic macrophage functions by g interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58, 2675-2677 (1990
26. Byrd TF. Tumor necrosis factor a (TNF a) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNF a from iron-treated infected monocytes. J. Clin. Invest. 99(10), 2518-2529 (1997 (Pubitemid 27227731)
27. Voskuil MI, Schnappinger D, Visconti KC et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198(5), 705-713 (2003 (Pubitemid 37087770)
28. Mitra DK, Rajalingam R, Taneja V, Bhattacharyya BC, Mehra NK. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells. Clin. Immunol. Immunopathol. 82(1), 60-67 (1997 (Pubitemid 27049073)
29. Bendtzen K, Morling N, Fomsgaard A et al. Association between HLA-DR2 and production of tumour necrosis factor a and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28(5), 599-606 (1988 (Pubitemid 19035716)
30. Yadav AB, Muttil P, Singh AK et al. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis. Tuberculosis (Edinb.) 90(3), 188-196 (2010
31. WHO: Global tuberculosis control - surveillance, planning, financing (2007). www.who.int/tb/publications/global- report/2007/en
32. Broad Institute. Haploview. www.broad.mit.edu/mpg/haploview